APP and Alzheimer disease: APPswe/PS1-dE9 [(amyloid precursor protein/presenilin protein 1 (APP/PS1)] double-transgenic mouse model, which is characteristic of Aβ plaque deposition, gliosis, and cognitive impairment46, is adopted to check in vivo therapeutic efficiency of chiral Au NPs for AD.